EcoDrugPlus

Adrenoceptor Beta 3a

Ensembl ID : ENSMAMG00000009284
Gene Symbol: ADRB3A
3 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1-Like

Ensembl ID : ENSMAMG00000008634
Gene Symbol: LOC113142019
2 Cross references
345 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B10-Like

Ensembl ID : ENSMAMG00000008607
Gene Symbol: LOC113142298
2 Cross references
343 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSMAMG00000011084
Gene Symbol: LOC113132327
2 Cross references
194 Possible Orthologues:

Alpha-2a Adrenergic Receptor-Like

Ensembl ID : ENSMAMG00000018222
Gene Symbol: LOC113131949
2 Cross references
159 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSMAMG00000011688
Gene Symbol: LOC113124124
2 Cross references
149 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSMAMG00000014342
Gene Symbol: LOC113124561
3 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSMAMG00000021873
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSMAMG00000000429
Gene Symbol: AOC2
2 Cross references
404 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSMAMG00000022137
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSMAMG00000015611
Gene Symbol: LOC113123242
2 Cross references
205 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSMAMG00000011824
Gene Symbol: AR
4 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).